SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008486
Filing Date
2017-11-08
Accepted
2017-11-08 08:24:31
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20170930x10q.htm 10-Q 1179344
2 EX-31.1 glyc-20170930ex311f77aa8.htm EX-31.1 18177
3 EX-31.2 glyc-20170930ex312e6ac77.htm EX-31.2 17228
4 EX-32.1 glyc-20170930ex321dc5ef0.htm EX-32.1 10281
  Complete submission text file 0001558370-17-008486.txt   4562812

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20170930.xml EX-101.INS 982185
6 EX-101.SCH glyc-20170930.xsd EX-101.SCH 27740
7 EX-101.CAL glyc-20170930_cal.xml EX-101.CAL 29219
8 EX-101.DEF glyc-20170930_def.xml EX-101.DEF 129341
9 EX-101.LAB glyc-20170930_lab.xml EX-101.LAB 273944
10 EX-101.PRE glyc-20170930_pre.xml EX-101.PRE 229509
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 171185180
SIC: 2834 Pharmaceutical Preparations